Sumi, Toshiyuki
Nagano, Yutaro
Yokoo, Keiki
Ishikawa, Tatsuru
Nishikiori, Hirotaka
Honjo, Osamu
Kudo, Sayaka
Yamazoe, Masami
Kondoh, Shun
Shioya, Makoto
Otsuka, Mitsuo
Hashimoto, Midori
Yabe, Hayato
Tanaka, Yusuke
Sudo, Yuta
Yanagi, Masahiro
Takahashi, Mamoru
Chiba, Hirofumi
Article History
Received: 13 August 2024
Accepted: 10 November 2024
First Online: 3 January 2025
Declarations
:
: Financial Interests: Dr Toshiyuki Sumi reported personal fee from Ono Pharmaceutical and AstraZeneca outside the submitted work. Other authors declare they have no financial interests.
: This study was conducted with the approval of the Institutional Review Board of Sapporo Medical University Hospital (352–103) and was performed in accordance with the provisions of the Declaration of Helsinki.
: Informed consent was not obtained from all patients; instead, the opt-out method was used. Comprehensive information about the research was made available at the hospital facility and website.
: Not applicable.